Human KidneyMAP™ version 1.0
The RBM KidneyMAP™ panels detect early signs of renal damage within the kidney. Kidney toxicity is a major hurdle in many drug development programs. Sensitive and quantitative methods to detect drug-induced kidney damage will allow researchers to efficiently prioritize medicinal chemistry programs and accelerate decisions on pre-clinical and clinical testing protocols.
|
1. Alpha-1 Microglobulin * Urine Only |